![]() |
|
|
-Aminobutyric Acid-Glutamine Cycling in Rodent and Human Cortex: the Central Role of Glutamine1 ,2

Departments of
*
Psychiatry and
Diagnostic Radiology, Magnetic Resonance Center for Research in Metabolism and Physiology, Yale University School of Medicine, New Haven, CT 06520
3To whom correspondence should be addressed. E-mail: Kevin.behar{at}yale.edu.
| ABSTRACT |
|---|
|
|
|---|
-aminobutyric acid (GABA), the major excitatory and
inhibitory neurotransmitters, is linked to a substrate cycle between
neurons and astrocytes involving glutamine. However, the quantitative
significance of these fluxes in vivo was not known. Recent in vivo
13C and 15N NMR studies in rodents and
13C NMR in humans indicate that glutamine synthesis is
substantial and that the total glutamate-GABA-glutamine cycling flux,
necessary to replenish neurotransmitter glutamate and GABA, accounts
for >80% of net glutamine synthesis. In studies of the rodent cortex,
a linear relationship exists between the rate of glucose oxidation and
total glutamate-GABA-glutamine cycling flux over a large range of
cortical electrical activity. The molar stoichiometric relationship
(
1:1) found between these fluxes suggests that they share a common
mechanism and that the glutamate-GABA-glutamine cycle is coupled to a
major fraction of cortical glucose utilization. Thus, glutamine appears
to play a central role in the normal functional energetics of the
cerebral cortex.
KEY WORDS: glutamine glutamate-glutamine cycle neuron astrocyte trafficking NMR cerebral glucose utilization
| INTRODUCTION |
|---|
|
|
|---|
-aminobutyric acid
(GABA)4
in specialized excitatory and inhibitory neurons. The existence of
carbon cycles involving glutamate, GABA and glutamine have been
recognized for nearly 30 years, although the quantitative significance
of these pathways in relation to glucose metabolism and neuronal
energetics is not known.
The development and application of nuclear magnetic resonance (NMR)
spectroscopy to studies of the brain has permitted carbon and nitrogen
metabolism to be assessed in vitro and in vivo using
13C and 15N isotopically
labeled substrates (Badar-Goffer et al. 1990 and 1992
,
Cerdán et al. 1990
, Fitzpatrick et al. 1990
, Gruetter et al. 1994 and 1998
),
Kanamori and Ross 1993
, Rothman et al. 1985
, Shank et al. 1993
, Shen et al. 1998 and 1999
, Sibson et al. 1997, 1998a and 1998b
;
[see reviews by Bachelard (1998)
, Cruz and Cerdán (1999)
, Rothman et al. (1999)
and
Westergaard et al. (1995)
]. 13C
and 15N NMR have become major tools with which to
study brain energy metabolism and substrate trafficking between neurons
and astrocytes.
Until recently, the contribution of glutamate and GABA neurotransmitter
cycling to glutamine synthesis was thought to represent a smaller
fraction of its total synthesis, with the majority associated with
ammonia detoxification. However, measurements of the fluxes of
glutamine synthesis, glutamate-glutamine cycling and glucose
oxidation in vivo using 13C NMR have revealed the
glutamate-glutamine cycle to constitute a large flux, far greater
than that associated with detoxification under physiologic conditions.
Perhaps of greater significance, these studies provide evidence that
the glutamate-glutamine neurotransmitter cycle and glucose
utilization are functionally coupled. The new findings both support and
extend a recent proposal in which glutamate release and its
sodium-dependent uptake by astrocytes couples astroglial glucose
utilization to glutamatergic neuronal activity (Pellerin and Magistretti 1994
).
The present article describes the biochemical and molecular basis for the glutamate-GABA-glutamine cycle and evidence from recent in vivo 13C and 15N NMR studies conducted in our laboratory that this cycle plays a central role in brain glucose metabolism.
| The glutamate-glutamine cycle: biochemical and molecular considerations |
|---|
|
|
|---|
| Specialized transporters clear interstitial glutamate and GABA during synaptic activity |
|---|
|
|
|---|
The rapid clearance of transmitter glutamate from the synapse is
accomplished by the Na+-dependent, high affinity,
glutamate transporter proteins. Three glutamate transporters (GLT) have
been identified in the cerebrum, the astroglial transporters,
glutamate-aspartate transporter and GLT1 [or their human
homologs, excitatory amino acid transporters (EAAT)1 and EAAT2,
respectively], and the neuronal transporter, excitatory amino acid
carrier (EAAC)1/EAAT3 (Chaudhry et al. 1995
,
Kanai and Hediger 1992
, Rothstein et al. 1994 and 1996
). Two other neuronal transporters, EAAT4 and EAAT5, are
expressed on cerebellar GABAergic Purkinje cells and in the retina,
respectively, and appear to differ from their cortical counterparts in
gating Cl- ions (Arriza et al. 1997
, Fairman et al. 1995
, Yamada et al. 1996
). Although the functions of the neuronal transporters are
not yet clear, one of them (EAAC1) is expressed on some GABAergic nerve
terminals (Kanai and Hediger 1992
, Rothstein et al. 1994 and 1996
) where it may have a role in the supply of
precursor glutamate for GABA synthesis (Sepkuty et al. 2000
).
Evidence from molecular (Rothstein et al. 1996 and 1994
)
and electrophysiologic studies (Bergles and Jahr 1997 and 1998
) indicates that the astroglial transporters clear the
majority of glutamate from the synaptic cleft. As discussed
subsequently, the molecular findings are consistent with in vivo NMR
study results showing that glutamate uptake into astroglia and its
conversion to glutamine is the predominant path for recycling of
neuronal glutamate in vivo (Rothman et al. 1999
).
Glutamate transport is electrogenic and driven by the electrochemical
potential gradients of Na+,
K+ and H+. Studies of the
stoichiometry of GLT1 show glutamate uptake to be coupled to
cotransport of 3 Na+ and 1
H+ and countertransport of 1
K+ (Levy et al. 1998
). The
cotransport of Na+ with glutamate has been
reported to stimulate
Na+/K+-ATPase and glucose
utilization in cultured astrocytes (Pellerin and Magistretti 1994
, Sokoloff et al. 1996
). As explained below,
an extension of this molecular mechanism has been proposed to explain
the 1:1 flux stoichiometry discovered between cortical glucose
oxidation and glutamate-glutamine cycling.
GABA transport.
Astroglia and neurons possess a high capacity for the transport of GABA
(Henn and Hamberger 1971
, Hertz et al. 1978
, Ryan and Roskoski 1977
). Molecular cloning
studies have identified four high affinity, Na+
and Cl--dependent, GABA transporters (GAT) in
the brain (GAT1, GAT2, GAT3, GAT4/BGT-1). With the exception of GAT-3,
which is expressed on astrocytes, the other GAT subtypes are expressed
on both neurons and astrocytes (Minelli et al. 1995 and 1996
, Ribak et al. 1996
). The functional roles
of the different GABA transporter subtypes in the clearance of GABA
from synaptic, and possibly extrasynaptic sites remain to be
elucidated. Rapid metabolism of GABA in astrocytes via an active
GABA-transaminase (Chan-Palay et al. 1979
,
Larsson and Schousboe 1990
) maintains GABA at a low
level in these cells, resulting in a large concentration gradient
between GABAergic neurons and the surrounding transporter-rich
astroglia. GABA synthesis depends on glutamine for its supply of
glutamate precursors in vitro and in vivo (Balazs et al. 1973
, Patel et al. 2000
, Sonnewald et al. 1993
, Van den Berg 1972
), indicating that some
fraction of GABA released from GABAergic neurons is not recycled
directly back into the terminal. Thus, it appears likely that
astroglial uptake could be as important for GABA as it is for
glutamate.
Astroglial metabolism of extracellular glutamate and GABA stimulates glutamine synthesis.
Glutamine synthesis in astroglia is generally considered the major
net metabolic pathway for the metabolism of extracellular
glutamate (Wanienski and Martin 1986
). GABA metabolism
in astroglia can also lead to glutamine synthesis. Unlike glutamate,
however, GABA must be further processed in the astroglial tricarboxylic
acid (TCA) cycle, a two-step reaction involving
-ketoglutarate
and NAD+ that converts GABA to succinic acid via
GABA-transaminase (GABA-T) and succinic semialdehyde dehydrogenase.
The initial transamination between GABA and
-ketoglutarate catalyzed
by GABA-T produces glutamate, which may then proceed to formation
of glutamine.
Glutamine is not the only pathway for the metabolism of extracellular
glutamate in astroglia. Significant oxidation of extracellular
glutamate was reported by Yu et al. (1982)
in cultured
astrocytes although McKenna et al. (1996)
showed this
process to be dependent on the concentration of extracellular
glutamate. Net oxidation of glutamate and GABA carbon can occur in
astrocytes through the pyruvate recycling pathway, which involves malic
enzyme (Cruz et al. 1998
, Haberg et al. 1998
, McKenna et al. 1995
). In the study of
McKenna et al. (1996)
, oxidation was significant for
extracellular glutamate levels above
100 µmol/L, which
is far greater than estimated normal levels (Levy et al. 1998
), and within the range considered to be excitotoxic
(Choi et al. 1987
). Thus, glutamate oxidation may be of
pathophysiologic significance when neuronal release exceeds uptake
(e.g., ischemia or epileptic seizures). Evidence for oxidation of
glutamate and GABA after transient ischemia in vivo has been reported
(Pascual et al. 1998
). Pyruvate recycling and malic
enzyme may play an important role in the generation of NADPH to
maintain reduced glutathione (Vogel et al. 1999
), which
is highly concentrated in astroglia. Glutathione has been shown to
protect glia against free radical damage associated with glutamate
excitotoxicity (Chen et al. 2000
). As discussed
subsequently, results of 13C and
15N NMR studies of rat and human cerebral cortex
indicate that under normal physiologic conditions, glutamine synthesis
is favored by far over oxidation (and anaplerosis) as the major pathway
of glutamate neurotransmitter recycling.
| Glutamine transporters mediate the flow of glutamine from astrocytes to neurons |
|---|
|
|
|---|
Glutamine is a precursor for the resynthesis of neuronal glutamate and GABA.
Mature neurons do not contain the necessary anaplerotic enzymes to
resynthesize glutamate and GABA lost during neurotransmission and
depend on astrocytes to supply the needed carbon (Cooper and Plum 1987
, Kaufman and Driscoll 1993
,
Martin 1995
). Phosphate-activated glutaminase (PAG)
is a mitochondrial enzyme, present mainly in neurons but also reported
in glia (Hogstad et al. 1988
, Wiesinger 1995
), which converts glutamine to glutamate and ammonia.
Highly enriched in glutamatergic and GABAergic neurons, PAG provides an
important pathway to replenish neurotransmitter stores of glutamate and
GABA from glutamine. Addition of isotopically labeled glutamine to
isolated nerve terminals, neuronal cell cultures, brain slices and in
vivo results in labeling of both cellular and extracellular glutamate
(Sonnewald et al. 1993
, Wanienski and Martin 1986
, Ward et al. 1983
). Application of
6-diazo-5-oxo-L-norleucine, a potent and selective
inhibitor of PAG, to the rat cortex in vivo results in a rapid (<30
min) but reversible loss of glutamate immunostaining in pyramidal cell
bodies and dendrites, which returns over the course of several days
(Conti and Minelli 1994
). In vitro studies have shown
that in addition to glutamine, malate and
-ketoglutarate may serve
as carbon sources for repletion of neuronal glutamate and GABA
(Peng et al. 1993
, Shank and Campbell 1984
). However, as described subsequently, results of in vivo
NMR studies of the rat and human cortex suggest that glutamine is the
major precursor of neuronal glutamate and possibly GABA as well.
| In vivo NMR studies of the role of glutamine in the glutamate-glutamine cycle |
|---|
|
|
|---|
| Development of a quantitative approach to interpret glutamine metabolism in terms of glutamate neurotransmitter cycling and de novo (anaplerotic) synthesis |
|---|
|
|
|---|
-ketoglutarate in the astroglial TCA cycle, followed
by synthesis of glutamate either by glutamate dehydrogenase (GDH) or
transamination, and the synthesis of glutamine by GS complete this
pathway (Vana). Thus, at steady state,
glutamine efflux must be balanced by anaplerotic glutamine synthesis.
For each carbon skeleton of glutamine formed through anaplerosis,
between 1 and 2 nitrogen atoms can be removed, depending on the
relative rates of GDH and transamination. Thus, as described in
Sibson et al. (1997)
![]() | (1) |
![]() | (2) |
Thus, Vcycle can be derived from a measurement of glutamine synthesis if one of the other fluxes is either known or can be measured.
|
| Measurements of glutamine synthesis during hyper- and normoammonemia: experimental validation of a model of glutamate-glutamine cycling |
|---|
|
|
|---|
Glutamine levels increase throughout the brain during hyperammonemia
(Cooper and Plum 1987
). Under appropriate experimental
conditions, hyperammonemia can be used to test the validity of
relationships predicted by the metabolic model. After a prolonged
infusion of ammonium acetate in rats, a metabolic steady state can be
achieved in which the glutamine level and rate of synthesis
(Vgln), although elevated, remain
constant. In the absence of changes in
Vcycle the increase in
Vgln with hyperammonemia would be
predicted by Equation (2)
to equal the increase in de novo
(anaplerotic) glutamine synthesis
(
Vana) and glutamine efflux
(
Vefflux).
Steady-state values of VTCA and
Vgln were determined for the cortex of
hyperammonemic and control rats using 13C NMR
(Sibson et al. 1997
). The enrichment time courses of
glutamine and glutamate were measured during an infusion of
[1-13C]glucose (Fig. 2
), and the two fluxes were evaluated from the best fit of the metabolic
model to the enrichment data. VTCA was
not significantly different from control [0.57 ± 0.16 vs. 0.46
± 0.12 µmol/(g · min)], whereas
Vgln was increased by 0.11 ± 0.07 µmol/(g · min). The comparable increase [
0.1
µmol/(g · min)] in
Vana and
Vefflux predicted on the basis of
Equations (1) and (2)
is consistent with published reports of these
fluxes measured in hyperammonemic animals using
14C isotopes and arteriovenous differences
(Dejong et al. 1992
, Waelsch et al. 1964
).
|
32% of the glutamine
synthesis flux but only 1723% under physiologic conditions in the
cortex of anesthetized adult rats (Sibson et al. 2001In vivo 15N NMR measurements of acute hyperammonemia.
Nitrogen metabolism can be assessed directly in the brain using
15N-labeled substrates and
15N NMR in vitro and in vivo (Kanamori and Ross 1993 and 1995
, Shen et al. 1998
).
Incorporation of 15N-labeled ammonia into
glutamine N5 is a direct measure of the flux through glutamine
synthetase, whereas isotopic labeling of (glutamate + glutamine) N2
reflects sequential flow through glutamate dehydrogenase (GDH) and GS.
The flux of ammonia transported into the brain and fixed as glutamine
(Vtrans) was estimated from the sum of
15N labeling of N5 (glutamine) and N2 (glutamate
+ glutamine), which represented the major
15N-labeled resonances detected in the spectra
(Fig. 3
). The ammonia transport flux determined in the
15N NMR experiment,
Vtrans = 0.13 ± 0.02
µmol/(g · min), may be related to anaplerotic
glutamine synthesis through the 1:2 stoichiometric relationship of
their fluxes (i.e.,
Vana = 0.5
Vtrans). The value reported
for Vana of 0.065
µmol/(g · min) is somewhat lower than that given in
the [2-13C]glucose experiment and can be
ascribed to the observed delay (
1 h) in the labeling of glutamine N2
compared with N5 (Shen et al. 1998
). This lag may
reflect either a delay in the stimulation of anaplerosis and/or an
inflow of unlabeled N2 nitrogen from transamination with
branched-chain amino acids (Yudkoff 1997
). A close
correspondence was found between the initial rate of
glutamine synthesis (when anaplerosis flux is low) during acute
hyperammonemia using 15N NMR [0.20 ± 0.06
µmol/(g · min); Shen et al. 1998
] and
13C NMR using
[1-13C]glucose [0.21 ± 0.04
µmol/(g · min); Sibson et al. 1997
]. Thus, the results of the nonsteady-state
15N NMR study indicate that even under conditions
of acute hyperammonemia, anaplerosis represents a smaller fraction (in
this case, approximately one third) of total glutamine synthesis with
the larger fraction (approximately two thirds) contributed by glutamate
neurotransmitter recycling. Under normal physiologic conditions in
which blood ammonia levels are low, glutamate neurotransmitter
recycling represents >80% of glutamine synthesis.
|
| The rate of glutamine synthesis is proportional to electrical and metabolic activity supporting a direct link to function |
|---|
|
|
|---|
80%) to the corresponding rate of neuronal glucose
oxidation and between 60 and 80% of total cerebral glucose oxidation.
Because oxygen and glucose utilization rates (Hyder et al. 1996
1.0 and y-intercept
(where Vcycle = 0 and the cortex
is electrically silent) of 0.1 µmol/(g · min)
(Fig. 4
|
| CONCLUSIONS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
2 Supported by research grants from the National
Institutes of Health NS34813, HD32573, NS32126 and DK27121. ![]()
4 Abbreviations used: CMRglu(ox),
cerebral metabolic rate of glucose oxidation; EAAC, excitatory amino
acid carrier; EAAT, excitatory amino acid transporter; EEG,
electroencephalogram; GABA,
-aminobutyric acid; GABA-T, GABA
transaminase; GAT, GABA transporter; GDH, glutamate dehydrogenase; GLT,
glutamate transporter; GS, glutamine synthetase; NMR, nuclear magnetic
resonance; PAG, phosphate-activated glutaminase; PC, pyruvate
carboxylase; PDH, pyruvate dehydrogenase; TCA, tricarboxylic acid
cycle; Vana, anaplerotic glutamine synthesis flux;
VCO2, carbon dioxide fixation flux; Vcycle,
glutamate-glutamine cycle flux; Vefflux, net ammonia
transported out of the brain; Vgln, glutamine synthesis
flux; VTCA, TCA cycle flux; Vtrans, net ammonia
transported into the brain. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1.
Arriza J. L., Eliasof S., Kavanaugh M. P. & Amara S. G. (1997) Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U.S.A. 94:4155-4160.
2. Bachelard H. (1998) Landmarks in the application of 13C-magnetic resonance spectroscopy to studies of neuronal/glial relationships. Dev. Neurosci. 20:277-288.[Medline]
3. Badar-Goffer R. S, Bachelard H. S. & Morris P. G. (1990) Cerebral metabolism of acetate and glucose studied by 13C NMR spectroscopy: a technique for investigating metabolic compartmentation in the brain. Biochem. J. 266:133-139.[Medline]
4. Badar-Goffer R. S., Ben-Yoseph O., Bachelard H. S. & Morris P. G. (1992) Neuronal-glial metabolism under depolarizing conditions: a [13C]NMR study. Biochem. J. 282:225-230.
5. Balazs R., Machiyama Y. & Patel A. J. (1973) Balazs R. Cremer J. eds. Metabolic Compartmentation in the Brain 1973:57 Macmillan London, UK .
6. Bergles D. E. & Jahr C. E. (1997) Synaptic activation of glutamate transporters in hippocampal astrocytes. Neuron 19:1297-1308.[Medline]
7.
Bergles D. E. & Jahr C. E. (1998) Glial contribution to glutamate uptake at Schaffer collateral-commissural synapses in the hippcampus. J. Neurosci. 18:7709-7716.
8. Broer A., Brookes N., Ganapathy V., Dimmer K. S., Wagner C. A., Lang F. & Broer S. (1999) The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux. J. Neurochem. 73:2184-2194.[Medline]
9.
Cerdán S., Kunnecke B. & Seelig J. (1990) Cerebral metabolism of (1,2-13C2) acetate as detected by in vivo and in vitro 13C NMR. J. Biol. Chem. 265:12916-12926.
10.
Chan-Palay V., Wu J.-Y. & Palay S. L. (1979) Immunocytochemical localization of
-aminobutyric acid transaminase at cellular and ultrastructural levels. Proc. Natl. Acad. Sci. U.S.A. 76:2067-2071.
11. Chaudhry F. A., Lehre K. P., van Lookeren Campagne M., Ottersen O. P., Danbolt N. C. & Storm-Mathisen J. (1995) Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15:711-720.[Medline]
12. Chaudhry F. A., Reimer R. J., Krizaj D., Barber D., Storm-Mathisen J., Copenhagen D. R. & Edwards R. H. (1999) Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell 99:769-780.[Medline]
13. Chen C. J., Liao S. L. & Kuo J. S. (2000) Gliotoxic action of glutamate on cultured astrocytes. J. Neurochem. 75:1557-1565.[Medline]
14. Choi D. W., Maulucci-Gedde M. & Kriegstein A. R. (1987) Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:357-368.[Abstract]
15. Conti F. & Minelli A. (1994) Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase. J. Histochem. Cytochem. 42:717-726.[Abstract]
16.
Cooper A. J. & Plum F. (1987) Biochemistry and physiology of brain ammonia. Physiol. Rev. 67:440-519.
17. Cruz F. & Cerdán S. (1999) Quantitative 13C NMR studies of metabolic compartmentation in the adult mammalian brain. NMR Biomed 12:451-462.[Medline]
18. Cruz F., Scott S. R., Barroso I., Santisteban P. & Cerdán S. (1998) Ontogeny and cellular localization of the pyruvate recycling system in rat brain. J. Neurochem. 70:2613-2619.[Medline]
19. Dejong C. H., Kampman M. T., Deutz N. E. & Soeters P. B. (1992) Cerebral cortex ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J. Neurochem. 59:1071-1079.[Medline]
20. Fairman W. A., Vandenberg R. J., Arriza J. L., Kavanaugh M. P. & Amara S. G. (1995) An excitatory amino acid transporter with properties of a ligand-gated chloride channel. Nature (Lond.) 375:599-603.[Medline]
21. Fitzpatrick S. M., Hetherington H. P., Behar K. L. & Shulman R. G. (1990) The flux from glucose to glutamate in the rat brain in vivo as determined by 1H-observed, 13C-edited NMR spectroscopy. J. Cereb. Blood Flow Metab 10:170-179.[Medline]
22. Gruetter R., Novotny E. J., Boulware S. D., Mason G. F., Rothman D. L., Shulman G. I., Prichard J. W. & Shulman R. G. (1994) Localized 13C NMR spectroscopy in the human brain of amino acid labeling from [1-13C] D-glucose. J. Neurochem 63:1377-1385.[Medline]
23. Gruetter R., Seaquist E. R., Kim S. & Ugurbil K. (1998) Localized in vivo 13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla. Dev. Neurosci. 20:380-388.[Medline]
24. Haberg A., Qu H., Bakken I. J., Sande L. M., White L. R., Haraldseth O., Unsgard G., Aasly J. & Sonnewald U. (1998) In vitro and ex vivo 13C-NMR spectroscopy studies of pyruvate recycling in brain. Dev. Neurosci. 20:389-398.[Medline]
25.
Henn F. A. & Hamberger A. (1971) Glial cell function: uptake of transmitter substances. Proc. Natl. Acad. Sci. U.S.A. 68:2686-2690.
26. Hertz L., Wu P. H. & Schousboe A. (1978) Evidence for net uptake of GABA into mouse astrocytes in primary cultures: its sodium dependence and potassium independence. Neurochem. Res. 3:313-323.[Medline]
27. Hogstad S., Svenneby G., Torgner I. A., Kvamme E., Hertz L. & Schousboe A. (1988) Glutaminase in neurons and astrocytes cultured from mouse brain: kinetic properties and effects of phosphate, glutamate, and ammonia. Neurochem. Res. 13:383-388.[Medline]
28.
Hyder F., Chase J. R., Behar K. L., Mason G. F., Siddeek M., Rothman D. L. & Shulman R. G. (1996) Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation detected with. 1H[13C] NMR. Proc. Natl. Acad. Sci. U.S.A. 93:7612-7617.
29. Kanai Y. & Hediger M. A. (1992) Primary structure and functional characterization of a high affinity glutamate transporter. Nature (Lond.) 360:467-471.[Medline]
30. Kanamori K. & Ross B. D. (1993) 15N NMR measurement of the in vivo rate of glutamine synthesis and utilization at steady state in the brain of the hyperammonaemic rat. Biochem. J. 293:461-468.
31. Kanamori K. & Ross B. D. (1995) In vivo activity of glutaminase in the brain of hyperammonaemic rats measured in vivo by 15N nuclear magnetic resonance. Biochem. J. 305:329-336.
32. Kaufman E. E. & Driscoll B. F. (1993) Evidence for cooperativity between neurons and astroglia in the regulation of CO2 fixation in vitro. Dev. Neurosci. 15:299-305.[Medline]
33. Kvamme E. & Lenda K. (1982) Regulation of glutaminase by exogenous glutamate, ammonia and 2-oxoglutarate in synaptosomal enriched preparation from rat brain. Neurochem. Res 7:667-678.[Medline]
34. Larsson O. M. & Schousboe A. (1990) Kinetic characterization of GABA-transaminase from cultured neurons and astrocytes. Neurochem. Res. 15:1073-1077.[Medline]
35.
Levy L. M., Warr O. & Attwell D. (1998) Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake. J. Neurosci. 18:9620-9628.
36. Martin D. L. (1995) The role of glia in the inactivation of neurotransmitters. Kettenmann H. Ransom B.R. eds. Neuroglia 1995:732-745 Oxford University Press New York, NY. .
37.
Martinez-Hernandez A., Bell K. P. & Norenberg M. D. (1977) Glutamine synthetase: glial localization in brain. Science (Washington DC) 195:1356-1358.
38. Mason G. F., Petersen K., Shen J., Behar K. L., Petroff O.A.C., Shulman G. I. & Rothman D. L. (2000) Measurement of the rate of pyruvate carboxylase in human brain by 13C NMR. Abst. Int. Soc. Magn. Reson. Med. 1:422(abs.).
39. McKenna M. C., Sonnewald U., Huang X., Stevenson J. & Zielke H. R. (1996) Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes. J. Neurochem. 66:386-393.[Medline]
40. McKenna M. C., Tildon J. T., Stevenson J. H., Huang X. & Kingwell K. G. (1995) Regulation of mitochondrial and cytosolic malic enzymes from cultured rat brain astrocytes. Neurochem. Res. 20:1491-1501.[Medline]
41. Minelli A., Brecha N. C., Karschin C., DeBiasi S. & Conti F. (1995) GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J. Neurosci. 15:7734-7746.[Abstract]
42.
Minelli A., DeBiasi S., Brecha N. C., Zuccarello L. V. & Conti F. (1996) GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex. J. Neurosci. 16:6255-6264.
43.
Pascual J. M., Carceller F., Roda J. M. & Cerdán S. (1998) Glutamate, glutamine and GABA as substrates for the neuronal and glial compartments after focal cerebral ischemia in rats. Stroke 29:1048-1057.
44. Patel A., Rothman D. L., Wang B. & Behar K. L. (2000) Glutamine is a significant precursor for GABA synthesis in the rat cortex following acute GABA-transaminase inhibition. Abst. Am. Soc. Neurochem., 31st Ann. Meeting, March 2529, Chicago, IL 2000.
45.
Pellerin L. & Magistretti P. J. (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U.S.A. 91:10625-10629.
46. Peng L., Hertz L., Huang R., Sonnewald U., Petersen S. B., Westergaard N., Larsson O. & Schousboe A. (1993) Utilization of glutamine and TCA cycle constituents as precursors for transmitter glutamate and GABA. Dev. Neurosci 15:367-377.[Medline]
47. Ribak C. E., Tong W. M. & Brecha N. C. (1996) GABA plasma membrane transporters, GAT-1 and GAT-3, display different distributions in the rat hippocampus. J. Comp. Neurol. 367:595-606.[Medline]
48.
Rothman D. L., Behar K. L., Hetherington H. P., den Hollander J. A., Bendall M. R., Petroff O. A. & Shulman R. G. (1985) 1H-Observe/13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain in vivo. Proc. Natl. Acad. Sci. U.S.A. 82:1633-1637.
49. Rothman D. L., Sibson N. R., Hyder F., Shen J., Behar K. L. & Shulman R. G. (1999) In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:1165-1177.[Medline]
50. Rothstein J. D., Dykes-Hoberg M., Pardo C. A., Bristol L. A., Jin L., Kuncl R. W., Kanai Y., Hediger M. A., Wang Y., Schielke J. P. & Welty D. F. (1996) Knockout of glutamate transporters reveal a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.[Medline]
51. Rothstein J. D., Martin L., Levey A. I., Dykes-Hoberg M., Jin L., Wu D., Nash N. & Kuncl R. W. (1994) Localization of neuronal and glial transporters. Neuron 13:713-725.[Medline]
52.
Ryan L. D. & Roskoski R., Jr (1977) Net uptake of gamma-aminobutyric acid by a high affinity synaptosomal transport system. J. Pharmacol. Exp. Ther. 200:285-291.
53. Schousboe A., Westergaard N., Sonnewald U., Petersen S. B., Huang R., Peng L. & Hertz L. (1993) Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev. Neurosci. 15:359-366.[Medline]
54. Sepkuty J. P., Behar K. L. & Rothstein J. D. (2000) Molecular knockdown of the glutamate transporter EAAC1 reduces new GABA synthesis in rat hippocampus 2000 Soc. Neurosci. Abstr New Orleans, LA. .
55.
Shank R. P. & Campbell G. L. (1984)
-Ketoglutarate and malate uptake and metabolism by synaptosomes: further evidence for an astrocyte to neuron metabolic shuttle. J. Neurochem. 42:1153-1161.[Medline]
56. Shank R. P., Leo G. C. & Zielke H. R. (1993) Cerebral metabolic compartmentation as revealed by nuclear magnetic resonance analysis of D-[1-13C]glucose metabolism. J. Neurochem. 61:315-323.[Medline]
57.
Shen J., Petersen K. F., Behar K. L., Brown P., Nixon T. W., Mason G., Petroff O.A.C., Shulman G. I., Shulman R. G. & Rothman D. L. (1999) Determination of the rate of the glutamate-glutamine cycle in the human brain by in vivo 13C NMR. Proc. Natl. Acad. Sci. U.S.A. 96:8235-8240.
58. Shen J., Sibson N. R., Cline G., Behar K. L., Rothman D. L. & Shulman R. G. (1998) 15N NMR spectroscopy studies of ammonia transport and glutamine synthesis in the hyperammonemic rat brain. Dev. Neurosci. 20:434-443.[Medline]
59.
Shulman R. G. & Rothman D. L. (1998) Interpreting functional imaging studies in terms of neurotransmitter cycling. Proc. Natl. Acad. Sci. U.S.A. 95:11993-11998.
60.
Sibson N. R., Dhankhar A., Mason G. F., Behar K. L., Rothman D. L. & Shulman R. G. (1997) In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc. Natl. Acad. Sci. U.S.A. 94:2699-2704.
61.
Sibson N. R., Dhankhar A., Mason G. F., Rothman D. L., Behar K. L. & Shulman R. G. (1998a) Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc. Natl. Acad. Sci. U.S.A. 95:316-321.
62. Sibson N. R., Mason G. F., Shen J., Cline G. W., Herskovits A. Z., Wall J.E.M., Behar K. L., Rothman D. L. & Shulman R. G. (2001) In vivo 13C NMR measurement of neurotransmitter glutamate cycling, anaplerosis, and TCA cycle flux in rat brain during [2-13C]glucose infusion in rat brain. J. Neurochem. 76:975-989.[Medline]
63. Sibson N. R., Shen J., Mason G. F., Rothman D. L., Behar K. L. & Shulman R. G. (1998b) Functional energy metabolism: in vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronal activity. Dev. Neurosci. 20:321-330.[Medline]
64. Siesjö B. K. (1978) Brain Energy Metabolism 1978 John Wiley & Sons New York, NY. .
65. Sokoloff L. (1993) Sites and mechanisms of function-related changes in energy metabolism in the nervous system. Dev. Neurosci. 15:194-206.[Medline]
66. Sokoloff L., Takahashi S., Gotoh J., Driscoll B. F. & Law M. J. (1996) Contribution of astroglia to functionally activated energy metabolism. Dev. Neurosci. 18:343-352.
67. Sonnewald U., Westergaard N., Schousboe A., Svendsen J. S., Unsgard G. & Petersen S. B. (1993) Direct demonstration by [13C]NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons. Neurochem. Int. 22:19-29.[Medline]
68. Szerb J. C. & ORegan P. A. (1985) Effect of glutamine on glutamate release from hippocampal slices induced by high K+ or by electrical stimulation: interaction with different Ca2+ concentrations. J. Neurochem. 44:1724-1731.[Medline]
69.
Tsacopoulos M. & Magistretti P. J. (1996) Metabolic coupling between glia and neurons. J. Neurosci. 16:877-885.
70. Van den Berg C. J. (1972) A model of compartmentation in mouse brain based on glucose and acetate metabolism. Balazs R. Cremer J.E. eds. Metabolic Compartmentation in the Brain 1972:137-166 John Wiley & Sons New York, NY. .
71.
Varoqui H., Zhu H., Yao D., Ming H. & Erickson J. D. (2000) Cloning and functional identification of a neuronal glutamine transporter. J. Biol. Chem. 275:4049-4054.
72. Vogel R., Wiesinger H., Hamprecht B. & Dringen R. (1999) The regeneration of reduced glutathione in rat forebrain mitochondria identifies metabolic pathways providing the NADPH required. Neurosci. Lett. 275:97-100.[Medline]
73. Waelsch H., Berl S., Rossi C. A., Clarke D. D. & Purpura D. P. (1964) Quantitative aspects of CO2 fixation in mammalian brain in vivo. J. Neurochem. 11:717-728.[Medline]
74. Wanienski R. A. & Martin D. L. (1986) Exogenous glutamate is metabolized to glutamine and exported by rat primary astrocyte cultures. J. Neurochem. 47:304-313.[Medline]
75. Ward H. K., Thanki C. M. & Bradford H. F. (1983) Glutamine and glucose as precursors of transmitter amino acids: ex vivo studies. J. Neurochem. 40:855-860.[Medline]
76. Westergaard N., Sonnewald U. & Schousboe A. (1995) Metabolic trafficking between neurons and astrocytes: the glutamate-glutamine cycle revisited. Dev. Neurosci. 17:203-211.[Medline]
77. Wiesinger H. (1995) Glia-specific enzyme systems. Kettenmann H. Ransom B. R. eds. Neuroglia 1995:488-499 Oxford University Press New York, NY. .
78. Yamada K., Watanabe M., Shibata T., Tanaka K., Wada K. & Inoue Y. (1996) EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses. Neuroreport 7:2013-2017.[Medline]
79.
Yao D., Mackenzie B., Ming H., Varoqui H., Zhu H., Hediger M. A. & Erickson J. D. (2000) A novel system A isoform mediating Na+/neutral amino acid cotransport. J. Biol. Chem. 275:22790-22797.